Can a transplant drug turn back the clock on aging hearts?
NCT ID NCT04742777
Summary
This study tested whether rapamycin, a drug used to prevent organ transplant rejection, could improve heart function in older adults. Researchers enrolled 20 healthy participants aged 70-95 and gave them rapamycin for 8 weeks. They used detailed heart MRI scans before and after treatment to measure changes in how well the heart pumps blood and how flexible the main artery is.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AGING are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Audie L. Murphy Memorial Veterans Hospital
San Antonio, Texas, 78229, United States
-
The University of Texas Health Science Center at San Antonio
San Antonio, Texas, 78229, United States
Conditions
Explore the condition pages connected to this study.